September 26, 2024
Discover key strategies for mastering CMC in drug development from industry leaders. Our blog covers expert insights on early-stage de-risking, CMO selection, and leveraging AI to drive success.
July 29, 2024
Proactive vendor evaluations, comprehensive domain expertise, and FDA-approved audits – DSI is your trusted partner for seamless 2024 GCP GMP audits.
July 26, 2024
Date: July 26, 2024 Location: Kansas City, MO DSI, a renowned pharmaceutical and animal health industry leader, is thrilled to announce its participation in the upcoming Animal Health Corridor Summit on August 26-27, 2024. This summit is a pivotal event for industry leaders, offering a platform for innovation, collaboration, and […]
July 26, 2024
Animal health depends upon veterinary medicine. Developing new medications not only safeguards animals from various diseases and conditions, but also helps prevent the transmission of zoonotic illnesses to humans. Central to this development is regulatory CMC (Chemistry, Manufacturing, and Controls), which focuses on the composition, manufacturing practices, and quality of […]
July 18, 2024
The costs of developing a new medication can amount to over $1 billion, depending on the complexity of the drug and expenses associated with unsuccessful studies. With these costs in mind, an optimized regulatory process is required to ensure that the procedures behind drug development are secure, safety-oriented, and reliable. […]
July 11, 2024
What principle does DSI prioritize for continuous improvement for quality management? How do these principles contribute to the advancement of quality management systems? Continuous improvement is an industry expectation. If you are using quality management systems on a daily basis, it is important to keep up with changes and trends […]
